Reviewing NeueHealth (NEUE) and Its Rivals

NeueHealth (NYSE:NEUE) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its competitors? We will compare NeueHealth to related companies based on the strength of its analyst recommendations, valuation, earnings, dividends, profitability, institutional ownership and risk.

Profitability

This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.12%	-1.59%	-0.02%

Valuation and Earnings

This table compares NeueHealth and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	9.44

NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for NeueHealth and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1116	2556	98	2.69

NeueHealth presently has a consensus target price of $8.00, suggesting a potential upside of 36.99%. As a group, “Hospital & medical service plans” companies have a potential upside of 17.68%. Given NeueHealth’s higher possible upside, equities analysts plainly believe NeueHealth is more favorable than its competitors.

Insider and Institutional Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility & Risk

NeueHealth has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, suggesting that their average share price is 5% less volatile than the S&P 500.

Summary

NeueHealth competitors beat NeueHealth on 9 of the 12 factors compared.

NeueHealth Company Profile

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.